Asklepios Nord Heidberg

Asklepios accounts for more than 40 percent of all hospital beds in Hamburg, and more than half of all operations are performed in one of the clinic’s central emergency departments.

“Asklepios Nord Heidberg improved its operating rooms in 2011: the highlight of the technical equipment is the intraoperative high-performance magnetic resonance imaging (MRI).

The high level of medical care is confirmed by CERTKOM and DIN EN ISO 9001:2015 certificates, as well as by the FOCUS rating, according to which Asklepios Nord Heidberg was ranked among the TOP German clinics in 2018.

“Asklepios Nord Heidberg” is one of the largest clinics, which provides a wide range of diagnostic and treatment services on an outpatient and inpatient basis. The main areas of work are oncology, neurosurgery, gastroenterology and ophthalmology. The chief physician of the neurosurgical department, Dr. Paul Kremer, and his team use predominantly minimally invasive and endoscopic techniques through small openings of 0.5 cm or less in the treatment of benign and malignant brain tumors, as well as in the removal of secondary metastases. With computer-assisted navigation, neurosurgeons can navigate neural tissues with millimeter accuracy, which is especially important for vascular anomalies (aneurysms, angiomas, and cavernomas) in confined spaces. Intraoperative neuromonitoring, on the other hand, prevents complications from interventions by regularly monitoring the condition of the brain, spinal cord and the cranial nerves exiting it. The oncology department covers almost all related therapeutic specialties, especially blood diseases. The department is equipped with all modern treatment methods from surgery to radiation and immunotherapy. The choice of therapy is determined by doctors at the consilium, each case is considered individually. The ophthalmology department of Asklepios Nord Heidberg treats age-related eye diseases such as macular degeneration, cataracts, glaucoma as well as inflammatory and traumatic injuries. As the largest department in Northern Germany, the department conducts its own developments in the field of age-related macular dystrophy and is ready to offer patients an innovative method of treating the wet form – course injections with drugs that slow down the pathological process.